Please Wait
Applying Filters...
menu
    • menu
    PharmaCompass Sponsored Ads

    Virtual Booth

    Contact Supplier

    Evonik

    Virtual Booth

    Contact Supplier

    Biophore is a research-driven global pharmaceutical company focused on niche APIs for the generic industry.

    Virtual Booth

    Contact Supplier

    Quotient Sciences- Molecule to Cure. Fast.

    Virtual Booth

    Contact Supplier

    ChemWerth works in generic API development & supply, non-infringement patent strategy development and regulatory support.

    Virtual Booth

    Contact Supplier

    jdmfs-not-supported-m-2025-04-28

    Virtual Booth

    An Enquiry

    Menu

    Dermoval

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    FINISHED DOSAGE FORMULATIONS

    DRUG PRODUCT COMPOSITIONS

    RELATED EXCIPIENT COMPANIES

    EXCIPIENTS BY APPLICATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    PATENTS & EXCLUSIVITIES

    REF. STANDARDS & IMPURITIES

    PharmaCompass
    $ API Ref.Price (USD/KG) : 969Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Formosa Pharmaceuticals Licenses Clobetasol Propionate to Apotex
    Formosa Pharmaceuticals Licenses Clobetasol Propionate to Apotex

    06 May 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/formosa-pharmaceuticals-announces-licensing-agreement-with-apotex-inc-for-commercialization-of-clobetasol-propionate-ophthalmic-suspension-for-post-ocular-surgery-inflammation-and-pain-for-mexico-302447818.html

    PR NEWSWIRE
    06 May 2025
    Share Share
    Class Action Over Generic Clobetasol And Clomipramine
    Class Action Over Generic Clobetasol And Clomipramine

    06 May 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/fine-kaplan-and-black-rpc-announce-class-action-lawsuits-on-behalf-of-those-who-paid-andor-reimbursed-for-generic-clobetasol-between-september-1-2014-and-december-31-2018-or-generic-clomipramine-between-august-1-2013-and--302446187.html

    PR NEWSWIRE
    06 May 2025
    Share Share
    Formosa Pharma & Saval Corporation License Clobetasol Propionate
    Formosa Pharma & Saval Corporation License Clobetasol Propionate

    25 Apr 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/formosa-pharmaceuticals-and-saval-corporation-announce-licensing-agreement-for-clobetasol-propionate-ophthalmic-suspension-for-the-treatment-of-post-operative-inflammation-and-pain-302438865.html

    PR NEWSWIRE
    25 Apr 2025
    Share Share
    Cipla and Formosa sign licensing deal for Clobetasol Suspension
    Cipla and Formosa sign licensing deal for Clobetasol Suspension

    18 Mar 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/cipla-and-formosa-sign-multi-regional-licensing-deal-for-clobetasol-suspension-302403405.html

    PR NEWSWIRE
    18 Mar 2025
    Share Share
    Formosa & Medvisis Announce Licensing Deal For Clobetasol
    Formosa & Medvisis Announce Licensing Deal For Clobetasol

    28 Nov 2024

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/formosa-pharmaceuticals-and-medvisis-switzerland-announce-licensing-agreement-for-clobetasol-propionate-ophthalmic-suspension-for-the-treatment-of-post-operative-inflammation-and-pain-302318160.html

    PR NEWSWIRE
    28 Nov 2024
    Share Share
    Formosa & DÁVI Farmacêutica Announce Clobetasol Licensing Deal
    Formosa & DÁVI Farmacêutica Announce Clobetasol Licensing Deal

    31 Oct 2024

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/formosa-pharmaceuticals-and-davi-farmaceutica-announce-licensing-agreement-for-clobetasol-propionate-ophthalmic-suspension-for-the-treatment-of-post-operative-inflammation-and-pain-302292975.html

    PR NEWSWIRE
    31 Oct 2024
    Share Share